Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy
Download
Timpani et al_Orphanet J Rare Diseases_2017.pdf
- Published Version
(639kB)
| Preview
Available under license: Creative Commons Attribution (external link)
Export
Timpani, Cara ORCID: 0000-0003-4567-4319 (external link), Hayes, Alan
ORCID: 0000-0003-1398-3694 (external link) and Rybalka, Emma
ORCID: 0000-0002-4854-0036 (external link)
(2017)
Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy.
Orphanet Journal of Rare Diseases, 12 (1).
100 - 100.
ISSN 1750-1172
Dimensions Badge
Altmetric Badge
Item type | Article |
URI | https://vuir.vu.edu.au/id/eprint/33704 |
DOI | 10.1186/s13023-017-0652-y (external link) |
Official URL | https://ojrd.biomedcentral.com/articles/10.1186/s1... (external link) |
Subjects | Historical > FOR Classification > 1109 Neurosciences Current > Division/Research > Institute for Health and Sport Current > Division/Research > College of Health and Biomedicine |
Keywords | Clinical trials; Duchenne muscular dystrophy; Neuronal nitric oxide synthase; Nitric oxide; Skeletal muscle; mdx mouse |
Citations in Scopus | 16 - View on Scopus (external link) |
Download/View statistics | View download statistics for this item |
CORE (COnnecting REpositories)